The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy

[1]  Tami D. Lieberman,et al.  Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis , 2016, Nature Medicine.

[2]  Liliana K. Rutaihwa,et al.  Mycobacterium tuberculosis Lineage 4 comprises globally distributed and geographically restricted sublineages , 2016, Nature Genetics.

[3]  F. Balloux,et al.  Antimicrobial Resistance in Mycobacterium tuberculosis: The Odd One Out. , 2016, Trends in microbiology.

[4]  S. Sampson.  Strength in Diversity: Hidden Genetic Depths of Mycobacterium tuberculosis. , 2016, Trends in microbiology.

[5]  R. Laxminarayan,et al.  Access to effective antimicrobials: a worldwide challenge , 2016, The Lancet.

[6]  Q. Gao,et al.  Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment , 2015, Scientific Reports.

[7]  F. Giardina,et al.  M. tuberculosis T Cell Epitope Analysis Reveals Paucity of Antigenic Variation and Identifies Rare Variable TB Antigens. , 2015, Cell host & microbe.

[8]  G. Bloemberg,et al.  Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. , 2015, The New England journal of medicine.

[9]  A. Pain,et al.  Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates , 2015, BMC Genomics.

[10]  Phelim Bradley,et al.  Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study , 2015, The Lancet. Infectious diseases.

[11]  J. Kitzman,et al.  Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs. , 2015, Cell host & microbe.

[12]  Thomas Abeel,et al.  Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal , 2015, PLoS medicine.

[13]  Matthew D. Zimmerman,et al.  The association between sterilizing activity and drug distribution into tuberculosis lesions , 2015, Nature Medicine.

[14]  C. Dye,et al.  Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study , 2015, PLoS medicine.

[15]  D. Mitchison,et al.  The early bactericidal activity of drugs in patients with pulmonary tuberculosis. , 2015, The American review of respiratory disease.

[16]  F. Balloux,et al.  Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain , 2015, Nature Communications.

[17]  V. Jansen,et al.  Five challenges in evolution and infectious diseases. , 2015, Epidemics.

[18]  N. Arinaminpathy,et al.  Seven challenges in modeling pathogen dynamics within-host and across scales. , 2015, Epidemics.

[19]  D. Brites,et al.  Co-evolution of Mycobacterium tuberculosis and Homo sapiens , 2015, Immunological reviews.

[20]  C. Barry,et al.  Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses , 2015, Immunological reviews.

[21]  S. Elena,et al.  Temporal dynamics of intrahost molecular evolution for a plant RNA virus. , 2015, Molecular biology and evolution.

[22]  T. C. White,et al.  The evolution of drug resistance in clinical isolates of Candida albicans , 2015, eLife.

[23]  Tatum D. Mortimer,et al.  Diversity of Mycobacterium tuberculosis across Evolutionary Scales , 2015, bioRxiv.

[24]  Daniel I. S. Rosenbloom,et al.  Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance , 2014, Proceedings of the National Academy of Sciences.

[25]  S. Molin,et al.  Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis , 2014, Nature Genetics.

[26]  F. Balloux,et al.  Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient , 2014, Genome Biology.

[27]  Francesc Coll,et al.  A robust SNP barcode for typing Mycobacterium tuberculosis complex strains , 2014, Nature Communications.

[28]  K. Reither,et al.  Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy , 2014, Drugs.

[29]  M. Uplekar,et al.  Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics. , 2014, Annals of the American Thoracic Society.

[30]  S. Cole,et al.  Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis , 2014, Antimicrobial Agents and Chemotherapy.

[31]  P. Hopewell.  Updating the international standards for tuberculosis care. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[32]  M. Murray,et al.  Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis. , 2014, The Journal of antimicrobial chemotherapy.

[33]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[34]  Roy Kishony,et al.  Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures , 2013, Nature Genetics.

[35]  S. Niemann,et al.  Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Beijing Strains in Patients , 2013, PloS one.

[36]  Koichiro Tamura,et al.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.

[37]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[38]  Razvan Sultana,et al.  Genomic Analysis Identifies Targets of Convergent Positive Selection in Drug Resistant Mycobacterium tuberculosis , 2013, Nature Genetics.

[39]  Dongfang Li,et al.  Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance , 2013, Nature Genetics.

[40]  K. Holt,et al.  Out-of-Africa migration and Neolithic co-expansion of Mycobacterium tuberculosis with modern humans , 2013, Nature Genetics.

[41]  P. V. van Helden,et al.  Programmatically Selected Multidrug-Resistant Strains Drive the Emergence of Extensively Drug-Resistant Tuberculosis in South Africa , 2013, PloS one.

[42]  Omar E. Cornejo,et al.  The Role of Selection in Shaping Diversity of Natural M. tuberculosis Populations , 2013, PLoS pathogens.

[43]  Chong-Jen Yu,et al.  Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan. , 2013, The Journal of antimicrobial chemotherapy.

[44]  Marc Lipsitch,et al.  Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug resistant tuberculosis , 2013, Nature Genetics.

[45]  Krishnendu Chatterjee,et al.  Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.

[46]  Richard G. Everitt,et al.  Within-Host Evolution of Staphylococcus aureus during Asymptomatic Carriage , 2013, PloS one.

[47]  Richard Smith,et al.  The true cost of antimicrobial resistance , 2013, BMJ.

[48]  S. Borrell,et al.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. , 2013, Trends in genetics : TIG.

[49]  Roy Kishony,et al.  Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance , 2013, Nature Reviews Genetics.

[50]  Weidong Tian,et al.  Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. , 2012, The Journal of infectious diseases.

[51]  Christopher A. Miller,et al.  Clonal Evolution Revealed by Whole Genome Sequencing in a Case of Primary Myelofibrosis Transformed to Secondary Acute Myeloid Leukemia , 2012, Leukemia.

[52]  A. Wilm,et al.  LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets , 2012, Nucleic acids research.

[53]  D. Pillay,et al.  Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis , 2012, The Lancet.

[54]  M. Götte,et al.  The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance. , 2012, Current opinion in virology.

[55]  Pardis C Sabeti,et al.  Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite , 2012, Proceedings of the National Academy of Sciences.

[56]  J. Pasipanodya,et al.  Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  J. O’Grady,et al.  Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. , 2012, The Journal of infectious diseases.

[58]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[59]  Leping Li,et al.  ART: a next-generation sequencing read simulator , 2012, Bioinform..

[60]  B. Birren,et al.  Independent Large Scale Duplications in Multiple M. tuberculosis Lineages Overlapping the Same Genomic Region , 2012, PloS one.

[61]  Brian Charlesworth,et al.  The Effects of Deleterious Mutations on Evolution at Linked Sites , 2012, Genetics.

[62]  Stefan Niemann,et al.  Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase , 2011, Nature Genetics.

[63]  Joanna B. Goldberg,et al.  Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes , 2011, Nature Genetics.

[64]  Haiyan Dong,et al.  Complete Genome Sequences of Mycobacterium tuberculosis Strains CCDC5079 and CCDC5080, Which Belong to the Beijing Family , 2011, Journal of bacteriology.

[65]  D. Falush,et al.  Helicobacter pylori genome evolution during human infection , 2011, Proceedings of the National Academy of Sciences.

[66]  Pia Abel zur Wiesch,et al.  Population biological principles of drug-resistance evolution in infectious diseases. , 2011, The Lancet. Infectious diseases.

[67]  Gaël Varoquaux,et al.  The NumPy Array: A Structure for Efficient Numerical Computation , 2011, Computing in Science & Engineering.

[68]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[69]  Robert J. Wilkinson,et al.  Changing Concepts of “Latent Tuberculosis Infection” in Patients Living with HIV Infection , 2010, Clinical & developmental immunology.

[70]  K. Kuhen,et al.  A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy , 2010, Nature Communications.

[71]  M. Reed,et al.  Massive Gene Duplication Event among Clinical Isolates of the Mycobacterium tuberculosis W/Beijing Family , 2010, Journal of bacteriology.

[72]  Remy Chait,et al.  Optimal Drug Synergy in Antimicrobial Treatments , 2010, PLoS Comput. Biol..

[73]  Remy Chait,et al.  Correction: Optimal Drug Synergy in Antimicrobial Treatments , 2010, PLoS Computational Biology.

[74]  J. Bayona,et al.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis , 2010, The Lancet.

[75]  J. Galagan,et al.  Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved , 2010, Nature Genetics.

[76]  W. Stephan.  Genetic hitchhiking versus background selection: the controversy and its implications , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.

[77]  Diarmaid Hughes,et al.  Antibiotic resistance and its cost: is it possible to reverse resistance? , 2010, Nature Reviews Microbiology.

[78]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[79]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[80]  Gregory S Turenchalk,et al.  Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. , 2009, The Journal of infectious diseases.

[81]  L. Hurst.  Genetics and the understanding of selection , 2009, Nature Reviews Genetics.

[82]  Stefan Niemann,et al.  High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography , 2008, PLoS biology.

[83]  J. Plotkin,et al.  The Population Genetics of dN/dS , 2008, PLoS genetics.

[84]  D. Hartl,et al.  Accelerated evolution of resistance in multidrug environments , 2008, Proceedings of the National Academy of Sciences.

[85]  Brian E. Granger,et al.  IPython: A System for Interactive Scientific Computing , 2007, Computing in Science & Engineering.

[86]  John D. Hunter,et al.  Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.

[87]  Richard S. Clifton-Hadley,et al.  Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis , 2006, Nature Reviews Microbiology.

[88]  C. D. Long,et al.  The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis , 2006, Science.

[89]  Marek Kimmel,et al.  simuPOP: a forward-time population genetics simulation environment , 2005, Bioinform..

[90]  Hinrich W. H. Göhlmann,et al.  A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis , 2005, Science.

[91]  Carl T. Bergstrom,et al.  Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[92]  M. Whitlock.  Fixation probability and time in subdivided populations. , 2003, Genetics.

[93]  Charles L Daley,et al.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. , 2003, American journal of respiratory and critical care medicine.

[94]  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis , 2002 .

[95]  N. White,et al.  The evolution of drug-resistant malaria: the role of drug elimination half-life. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[96]  T. Kenyon,et al.  Substandard tuberculosis drugs on the global market and their simple detection. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[97]  D. Mitchison,et al.  Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[98]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[99]  S Bonhoeffer,et al.  Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[100]  S. Weis,et al.  The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. , 1994, The New England journal of medicine.

[101]  Laura Pérez-Lago,et al.  Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. , 2014, The Journal of infectious diseases.

[102]  Stefan Niemann,et al.  Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes , 2011 .

[103]  Wes McKinney,et al.  Data Structures for Statistical Computing in Python , 2010, SciPy.

[104]  Skipper Seabold,et al.  Statsmodels: Econometric and Statistical Modeling with Python , 2010, SciPy.

[105]  Christopher Dye,et al.  Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis , 2009, Nature Reviews Microbiology.

[106]  H. Kishino,et al.  Dating of the human-ape splitting by a molecular clock of mitochondrial DNA , 2005, Journal of Molecular Evolution.

[107]  D. Mitchison.  How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.